One third of organ transplants are lost to transplant rejection. Although acute transplant rejection responds relatively well to steroids, chronic rejection (which is mainly mediated by antibodies) has no effective treatment. A newly discovered structure has revealed unexpected insights about the how antibodies in the recipient (alloantibodies) bind to the human leukocyte antigen (HLA) on the transplant. These insights will inform the development of novel therapies for chronic rejection.
Rejection of transplanted organs: Long-awaited structure offers new insights
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024
About admin
Now Dr. Jack Straw is in charge of the website, and organizes it so that medical care is available to everyone. In addition, he is an active member of the medical community, regularly attending international conferences and sharing his experience and knowledge.
Dr. Straw is not only a medical professional and website manager, but also a loving husband and father of his beautiful children.
View all posts by admin →